Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

MLN 8237 × Thoracic × 30 days × Clear all

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1 Lymphoid 1 Breast 1

Conditions

Small Cell Lung Carcinoma 1

Interventions

Carboplatin 102 pembrolizumab 93 Pemetrexed 75 Cisplatin 62 Paclitaxel 49 durvalumab 42 Specimen Handling 35 Nivolumab 29 atezolizumab 26 Magnetic Resonance Spectroscopy 25 Gemcitabine 25 Docetaxel 22 osimertinib 18 Radiotherapy 18 Etoposide 18 Radiosurgery 17 130-nm albumin-bound paclitaxel 17 Bevacizumab 15 Immunoglobulin G 14 Drug Therapy 13 Disulfides 13 Cetuximab 13 Biopsy 13 Taxes 12 Platinum 12 cemiplimab 11 Ipilimumab 10 1,2-diaminocyclohexaneplatinum II citrate 10 tislelizumab 8 Standard of Care 8

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07465757 2026-03-12

ALISCA-Lung2

Puma Biotechnology, Inc.

Phase 2 Not yet recruiting

Small Cell Lung Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡